Knowstox

Fundamentals snapshot

National Health Investors, Inc.

NHI · NYQ · Real Estate · REIT - Healthcare Facilities

Current price

$67.04

52-week range

$63.51 - $91.38

Market cap

$3.29B

One-glance verdict

Within fair range

$53.07 our estimate vs market $67.04

Wall Street consensus: $78.50 (47.9% higher than our fair-value estimate)

Balance sheet

Stretched

3.53x Stretched

Net debt $1.25B. Interest coverage shows how many times profit covers the interest bill.

What this company does

National Health Investors, Inc.

National Health Investors (NHI) is a company that owns and rents out buildings like senior living communities and hospitals. Most of their money comes from the rent these places generate, which is like a steady stream of income (recurring revenue). This is important because it shows they have a reliable way of making money from their properties.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $1.54M FY2024 Q4 $-75.54M FY2025 Q1 $-38.69M FY2025 Q3 $-3.03M FY2025 Q4 $-128.56M FY2026 Q1 $-55.98M
Revenue $121.32M
Net income $55.67M
Diluted EPS 1.15
Operating cash flow $64.97M
Free cash flow —
Revenue $115.13M
Net income $40.10M
Diluted EPS 0.82
Operating cash flow $53.44M
Free cash flow $-55.98M
Revenue $105.82M
Net income $38.16M
Diluted EPS 0.80
Operating cash flow $67.74M
Free cash flow $-128.56M
Revenue $89.85M
Net income $32.86M
Diluted EPS 0.69
Operating cash flow $62.53M
Free cash flow $-3.03M
Revenue $90.66M
Net income $36.99M
Diluted EPS 0.79
Operating cash flow $59.82M
Free cash flow —
Revenue $89.30M
Net income $34.16M
Diluted EPS 0.74
Operating cash flow $46.48M
Free cash flow $-38.69M
Revenue $85.75M
Net income $43.24M
Diluted EPS 0.96
Operating cash flow $57.57M
Free cash flow $-75.54M
Revenue $82.94M
Net income $28.54M
Diluted EPS 0.65
Operating cash flow $48.63M
Free cash flow $1.54M

Is it cheap or expensive?

Fair value $53.07 vs current price $67.04

Wall Street consensus is the average analyst price target: $78.50 (47.9% higher than our fair-value estimate).

Our most-likely fair value is $53.07 a share — about 20.8% away from today's price of $67.04, so the stock currently looks fairly priced.

fair

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 7.0% · Discount 7.2% · Terminal 2.5%

$53.07

Bear

Growth 2.5% · Discount 7.2% · Terminal 2.5%

$34.75

Bull

Growth 15.0% · Discount 7.2% · Terminal 2.5%

$98.86

Is it drowning in debt?

Stretched

Net debt $1.2B. Interest coverage 3.5x.

Net debt $1.25B
Interest coverage 3.53x

National Health Investors, Inc.'s profit covers its interest bill about 3.5 times over. which is stronger than most peers shown here.

Stretched
Worse cushion Baseline Better cushion
NHI BASELINE National Health Investors, Inc.

Total debt $1.28B Interest coverage 3.53x This is the baseline the peer rows are being compared against.

Total debt $2.63B Interest coverage 2.35x -34% vs NHI Carries about 1.5x less debt cushion than NHI.

Total debt $1.21B Interest coverage 4.91x +39% vs NHI Carries about 1.4x more debt cushion than NHI.

Total debt $779.49M Interest coverage 3.53x -0% vs NHI Has roughly the same debt cushion as NHI.

Total debt $4.03B Interest coverage 3.46x -2% vs NHI Has roughly the same debt cushion as NHI.

Total debt $10.32B Interest coverage 1.78x -50% vs NHI Carries about 2.0x less debt cushion than NHI.

What you should know

The case for and against NHI

3 Rewards 3 Risks

Rewards

  • Revenue grew 15.0% last year.
  • Returns 10.7% on equity, ahead of 50% of its peers.
  • Free cash flow was positive in 8/10 years.

Risks

  • Operating margin compressed from 47.7% to 41.1% over 3 years.
  • Forward P/E (19.4x) is higher than trailing (19.4x) - earnings are expected to drop.
  • Net debt grew 1.4% over 3 years.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
19.38x
Forward P/E
19.43x
P/B
2.10x
P/S
7.56x
EV/EBITDA
15.73x
PEG ratio
4.76x

Profitability

How much profit each dollar creates

Gross margin
73.9%
Operating margin
41.1%
Net margin
38.3%
ROE
10.7%
ROA
4.4%

Health

Liquidity and balance-sheet strength

Debt / equity
0.80x
Current ratio
1.82x
Quick ratio
1.20x
Total debt
$1.28B
Total cash
$30.39M

Growth

How the business has been compounding

Revenue TTM
$432.12M
Revenue 5Y CAGR
5.9%
EPS TTM
3.46
EPS 5Y CAGR
26.8%

Cash flow

How much cash the business throws off

Operating CF TTM
$248.68M
Free CF TTM
$-57.47M
FCF margin
-13.3%

Dividend

Shareholder payout

Yield
5.6%
Payout ratio
106.4%
Last ex-div date
2026-09-30